| RS1008544115 |
EMC10
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and variable seizures, Neurodevelopmental disorder with dysmorphic facies and variable seizures |
| RS1008555507 |
SLIT2
|
Health Risk |
Pathogenic |
Congenital anomaly of kidney and urinary tract, Congenital anomaly of kidney and urinary tract |
| RS1008561025 |
NADSYN1
|
Health Risk |
Pathogenic |
Vertebral, cardiac |
| RS1008611582 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex, Ogna type |
| RS1008621697 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly, Atypical hemolytic-uremic syndrome with thrombomodulin anomaly |
| RS1008634601 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Au-Kline syndrome, Au-Kline syndrome |
| RS1008637055 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1008642 |
CAV3
|
Health Risk |
Pathogenic |
Distal myopathy, Tateyama type |
| RS1008678288 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1008679317 |
SQSTM1
|
Health Risk |
Pathogenic |
Paget disease of bone 2, early-onset |
| RS1008686772 |
OTOA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1008733639 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1008745697 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Familial cancer of breast |
| RS1008758499 |
GABBR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS1008821019 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Inborn genetic diseases |
| RS1008834111 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1008862252 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Progressive familial heart block type IB |
| RS1008881855 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Cerebral palsy, Cerebral palsy |
| RS1008906426 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1008907564 |
NIPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 6 |
| RS1008984719 |
LOC111365204
|
Health Risk |
Pathogenic |
North Carolina macular dystrophy, Progressive bifocal chorioretinal atrophy |
| RS1009026527 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS1009050362 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS10090787 |
SNTB1
|
Health Risk |
association |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS1009090950 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1009131948 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1009209509 |
SBF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4B3 |
| RS1009289636 |
GDF1
|
Health Risk |
Pathogenic |
— |
| RS1009298200 |
ALG1
|
Health Risk |
Likely pathogenic |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS1009311413 |
ANKS6
|
Health Risk |
Pathogenic |
Nephronophthisis 16, Nephronophthisis 16 |
| RS1009407656 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1009412984 |
GHR
|
Health Risk |
Pathogenic |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS1009422076 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Deafness |
| RS1009435359 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1009457715 |
BCKDHB
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1009463279 |
TBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
DiGeorge syndrome, Cardiovascular phenotype |
| RS1009503062 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS1009552469 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1009557453 |
IFT43
|
Health Risk |
Likely pathogenic |
— |
| RS1009569366 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1009574694 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1009716258 |
CLCN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myotonia, autosomal recessive form |
| RS1009762900 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1009769670 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1009807148 |
DUOX2
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS1009822245 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1009828411 |
PRCD
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1009850780 |
GBA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Gaucher disease, Parkinson disease |
| RS1009872980 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1009877821 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS1009906758 |
AP3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1009925927 |
KMT2D
|
Health Risk |
Pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS1010033960 |
DHCR24
|
Health Risk |
Pathogenic/Likely pathogenic |
Non-immune hydrops fetalis, Non-immune hydrops fetalis |
| RS1010038586 |
TYR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TYR-related disorder |
| RS1010078101 |
ALDH3A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1010112210 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1010121578 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
MTOR-related disorder, Inborn genetic diseases |
| RS1010143466 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1010145375 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1010165716 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS1010183160 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1010184002 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 4B, Peroxisome biogenesis disorder |
| RS1010201937 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS1010235940 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 1, Stickler syndrome type 2 |
| RS1010245755 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1010285962 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
COACH syndrome 1, Meckel-Gruber syndrome |
| RS1010286043 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1010302320 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS1010327160 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1010331313 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1010347467 |
LRAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 14 |
| RS1010361619 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, Thrombocytopenia 2 |
| RS1010372555 |
POLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS1010403072 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome |
| RS1010431551 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1010446295 |
MEIOB
|
Health Risk |
Pathogenic |
Premature ovarian failure 23, Premature ovarian failure 23 |
| RS1010541689 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1010560546 |
PLK4
|
Health Risk |
Likely pathogenic |
— |
| RS1010575243 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS1010580453 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1010619841 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS1010666282 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1010722195 |
DONSON
|
Health Risk |
Pathogenic/Likely pathogenic |
Meier-Gorlin syndrome, Microcephaly |
| RS1010724201 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS1010745565 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS1010746038 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1010750511 |
RNF220
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS1010755325 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome 6 |
| RS1010772189 |
RP9
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 9, Retinitis pigmentosa 9 |
| RS1010784407 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2C, Febrile seizures |
| RS1010796800 |
COMP
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1010907740 |
GPAA1
|
Health Risk |
Likely pathogenic |
Glycosylphosphatidylinositol biosynthesis defect 15, Glycosylphosphatidylinositol biosynthesis defect 15 |
| RS1010909113 |
CYFIP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1010958758 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1010980331 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS1010982936 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinal dystrophy |
| RS1011045344 |
AP4E1
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1011076278 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1011096937 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1011135926 |
HPS6
|
Health Risk |
Pathogenic |
— |